Skip to main navigation
Skip to search
Skip to main content
Experts@Minnesota Home
Search content at Experts@Minnesota
Home
Profiles
Research units
University Assets
Projects and Grants
Research output
Datasets
Press/Media
Activities
Fellowships, Honors, and Prizes
Impacts
PMN and anti-tumor immunity-The case of bladder cancer immunotherapy
Erik L. Brincks
, Michael C. Risk
,
Thomas S. Griffith
Urology
Cancer Immunology
Research output
:
Contribution to journal
›
Review article
›
peer-review
34
Link opens in a new tab
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'PMN and anti-tumor immunity-The case of bladder cancer immunotherapy'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Tumor Immunity
100%
Bacillus Calmette-Guérin
100%
Polymorphonuclear Neutrophils
100%
Bladder Cancer Therapy
100%
Bladder Tumor
42%
TNF-related Apoptosis Inducing Ligand (TRAIL)
42%
Clinical Application
14%
Antitumor Activity
14%
Treatment Choice
14%
Non-muscle Invasive Bladder Cancer (NMIBC)
14%
Cancer Immunotherapy
14%
Tumor Progression
14%
Upper Tract Urothelial Carcinoma
14%
Immune Cells
14%
All Cancer
14%
Bladder
14%
Prophylactic Treatment
14%
Non-muscle Invasive
14%
Cancer Mortality
14%
First Use
14%
Intravesical Administration
14%
Granulocytes
14%
Cell Wall Components
14%
Surgical Therapy
14%
Apoptosis-inducing Activity
14%
Tumor Recurrence
14%
Biosynthetic Potential
14%
Urinary Levels
14%
Intracellular Stores
14%
Terminally Differentiated Cells
14%
Myelopoiesis
14%
Neutrophil Granules
14%
Production Localization
14%
Lifelong Follow-up
14%
Working Diagnosis
14%
Immunology and Microbiology
Neutrophil Granulocyte
100%
Tumor Immunity
100%
Mycobacterium Bovis BCG
100%
Cancer Immunotherapy
100%
TRAIL
42%
Tumor Necrosis Factor Related Apoptosis Inducing Ligand
42%
Muscle
28%
Cell Wall
14%
Granulocyte
14%
Antineoplastic Activity
14%
Immunocompetent Cell
14%
Mycobacterium bovis
14%
Cancer Mortality
14%
Myelopoiesis
14%
Neutrophil Granule
14%
Urine Level
14%
Programmed Cell Death
14%